Blog

Imagine an elite squad of soldiers sent to neutralize a hidden fortress, only to find themselves wandering aimlessly in a thick, disorienting fog just outside the gates. This is the current reality for many immunotherapy treatments: powerful immune cells are engineered to kill cancer, yet they often fail to even find the tumor. However, a revolutionary new approach is turning these 'lost' cells into biological bloodhounds, capable of sniffing out a tumor's unique chemical scent to lead a precision strike. Introduction For decades, the 'holy grail' of oncology has been the development of therapies that can distinguish between healthy tissue and malignant growths with absolute precision. Whil …